beLAB2122 provides drug discovery resources and expertise, thereby significantly reducing timelines and ensuring a greater success rate for emerging therapeutic concepts to reach preclinical and clinical proof-of-concept. We catalyse innovation to create sustainable companies.
Accelerating drug discovery
to bring science to patients faster
Building BRIDGES together
Accelerating drug discovery to bring science to patients faster
Building BRIDGES from academia to start-ups
From scouting promising science to propelling it through drug discovery infrastructure and expertise, beLAB2122 drives the process with the goal of transforming discoveries into potential medicines and viable start-up companies.
Building BRIDGES to increase drug discovery know-how
Enable your research discoveries to realize their full potential for the benefit of patients